- Home
- YMAB vs FTF Comparison
YMAB vs FTF Comparison
Compare YMAB & FTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMAB
- FTF
- Stock Information
- Founded
- YMAB 2015
- FTF 2003
- Country
- YMAB United States
- FTF United States
- Employees
- YMAB N/A
- FTF N/A
- Industry
- YMAB Biotechnology: Pharmaceutical Preparations
- FTF Finance/Investors Services
- Sector
- YMAB Health Care
- FTF Finance
- Exchange
- YMAB Nasdaq
- FTF Nasdaq
- Market Cap
- YMAB 218.4M
- FTF 253.3M
- IPO Year
- YMAB 2018
- FTF N/A
- Fundamental
- Price
- YMAB $3.89
- FTF $6.40
- Analyst Decision
- YMAB Buy
- FTF
- Analyst Count
- YMAB 11
- FTF 0
- Target Price
- YMAB $18.73
- FTF N/A
- AVG Volume (30 Days)
- YMAB 216.5K
- FTF 153.9K
- Earning Date
- YMAB 05-13-2025
- FTF 01-01-0001
- Dividend Yield
- YMAB N/A
- FTF 11.45%
- EPS Growth
- YMAB N/A
- FTF N/A
- EPS
- YMAB N/A
- FTF N/A
- Revenue
- YMAB $87,685,000.00
- FTF N/A
- Revenue This Year
- YMAB N/A
- FTF N/A
- Revenue Next Year
- YMAB $18.83
- FTF N/A
- P/E Ratio
- YMAB N/A
- FTF N/A
- Revenue Growth
- YMAB 3.38
- FTF N/A
- 52 Week Low
- YMAB $3.84
- FTF $5.76
- 52 Week High
- YMAB $17.47
- FTF $6.56
- Technical
- Relative Strength Index (RSI)
- YMAB 40.44
- FTF 58.91
- Support Level
- YMAB $3.76
- FTF $6.30
- Resistance Level
- YMAB $4.60
- FTF $6.25
- Average True Range (ATR)
- YMAB 0.33
- FTF 0.06
- MACD
- YMAB -0.02
- FTF 0.03
- Stochastic Oscillator
- YMAB 15.12
- FTF 97.88
About YMAB Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.
About FTF Franklin Limited Duration Income Trust of Beneficial Interest
Franklin Limited Duration Income Trust is a closed-end investment company based in the United States. It conducts its investment to provide high, current income, with a secondary objective of capital appreciation. To align with its investment objective is to invest in a diversified mix of fixed-income securities. Its portfolio is dominated by considerable investments in high-yield corporate bonds while touching upon other avenues such as senior secured floating rate corporate loans, mortgage-backed securities, commercial mortgage-backed securities, asset-backed securities, common stocks, and other short-term investments.